المؤلفون: Wang Z; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China., Zhang J; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China., Xia T; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China., He R; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China., Yan F; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China.

المصدر: Journal of biopharmaceutical statistics [J Biopharm Stat] 2024 Jul 03; Vol. 34 (4), pp. 582-595. Date of Electronic Publication: 2023 Jul 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9200436 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5711 (Electronic) Linking ISSN: 10543406 NLM ISO Abbreviation: J Biopharm Stat Subsets: MEDLINE

مواضيع طبية MeSH: Bayes Theorem* , Clinical Trials, Phase I as Topic*/statistics & numerical data , Clinical Trials, Phase I as Topic*/methods , Clinical Trials, Phase II as Topic*/statistics & numerical data , Clinical Trials, Phase II as Topic*/methods , Dose-Response Relationship, Drug* , Research Design*/statistics & numerical data , Computer Simulation*, Humans ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Logistic Models ; Neoplasms/drug therapy ; Linear Models ; Models, Statistical

المؤلفون: Yang CH; Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Cheng G; Guangzhou Institute of International Finance, Guangzhou University, Guangzhou, Guangdong, China., Lin R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

المصدر: Pharmaceutical statistics [Pharm Stat] 2024 Jul-Aug; Vol. 23 (4), pp. 585-594. Date of Electronic Publication: 2024 Feb 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 101201192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-1612 (Electronic) Linking ISSN: 15391604 NLM ISO Abbreviation: Pharm Stat Subsets: MEDLINE

مواضيع طبية MeSH: Bayes Theorem* , Maximum Tolerated Dose* , Dose-Response Relationship, Drug* , Clinical Trials, Phase I as Topic*/methods , Clinical Trials, Phase I as Topic*/statistics & numerical data , Antineoplastic Agents*/administration & dosage, Humans ; Logistic Models ; Neoplasms/drug therapy ; Research Design

المؤلفون: Fang J; Department of Statistics and Actuarial Science, The University of Hong Kong, Hong Kong, China., Yin G; Department of Statistics and Actuarial Science, The University of Hong Kong, Hong Kong, China.

المصدر: Statistics in medicine [Stat Med] 2024 Jul 30; Vol. 43 (17), pp. 3210-3226. Date of Electronic Publication: 2024 May 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 8215016 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0258 (Electronic) Linking ISSN: 02776715 NLM ISO Abbreviation: Stat Med Subsets: MEDLINE

مواضيع طبية MeSH: Clinical Trials, Phase I as Topic*/methods , Computer Simulation*, Humans ; Research Design ; Dose-Response Relationship, Drug ; Calibration ; Drug-Related Side Effects and Adverse Reactions ; Models, Statistical ; Time Factors

المؤلفون: Watanabe S; Department of Neurosurgery, Mito Kyodo General Hospital, Tsukuba University Hospital Mito Area Medical Education Center, 3-2-7 Miyamachi, Mito, 310-0015, Ibaraki, Japan. shinya-watanabey@md.tsukuba.ac.jp.; Department of Neurosurgery, Institute of Medicine, University of Tsukuba, Tsukuba, Japan. shinya-watanabey@md.tsukuba.ac.jp., Nonaka T; Department of Health and Medical Innovation, Graduate School of Medicine, Osaka Metropolitan University School, Osaka, Japan., Maeda M; Department of, Pharmacy, National Cancer Center Hospital, Tokyo, Japan., Yamada M; Tsukuba Clinical Research and Development Organization, University of Tsukuba, Tsukuba, Japan., Sugii N; Department of Neurosurgery, University of Tsukuba Hospital, Tsukuba, Japan., Hashimoto K; Tsukuba Clinical Research and Development Organization, University of Tsukuba, Tsukuba, Japan., Takano S; Department of Neurosurgery, University of Tsukuba Hospital, Tsukuba, Japan.; Tsukuba Clinical Research and Development Organization, University of Tsukuba, Tsukuba, Japan., Koyanagi T; Tsukuba Clinical Research and Development Organization, University of Tsukuba, Tsukuba, Japan., Arakawa Y; Tsukuba Clinical Research and Development Organization, University of Tsukuba, Tsukuba, Japan., Ishikawa E; Department of Neurosurgery, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.

المصدر: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Jul; Vol. 58 (4), pp. 655-662. Date of Electronic Publication: 2024 Mar 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101597411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2168-4804 (Electronic) Linking ISSN: 21684790 NLM ISO Abbreviation: Ther Innov Regul Sci Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/drug therapy , Clinical Trials, Phase I as Topic* , Endpoint Determination*, Humans ; Progression-Free Survival ; Treatment Outcome

المؤلفون: Maki A; Department of Clinical Medicine (Pharmaceutical Medicine), Graduate School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, 108-8641, Tokyo, Japan. dl20405@st.kitasato-u.ac.jp., Narukawa M; Department of Clinical Medicine (Pharmaceutical Medicine), Graduate School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, 108-8641, Tokyo, Japan.

المصدر: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Jul; Vol. 58 (4), pp. 766-772. Date of Electronic Publication: 2024 Apr 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101597411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2168-4804 (Electronic) Linking ISSN: 21684790 NLM ISO Abbreviation: Ther Innov Regul Sci Subsets: MEDLINE

مواضيع طبية MeSH: Clinical Trials, Phase I as Topic* , Drug Development*, Japan ; Humans ; Antineoplastic Agents/therapeutic use ; Neoplasms/drug therapy ; Multicenter Studies as Topic ; Research Design ; Medical Oncology ; Drug Industry

المؤلفون: Van Zyl M; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., Barell A; Senior Adult Oncology Programme, Royal Marsden Hospital, Sutton, UK., Cooley B; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., Hanwell J; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., Parlak J; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., Banerji U; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., De Bono J; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., Sharp A; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., Lopez J; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK., Battisti NML; Senior Adult Oncology Programme, Royal Marsden Hospital, Sutton, UK.; Breast Unit & Senior Adult Oncology Programme, Royal Marsden Hospital, Sutton, UK., Minchom A; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK.

المصدر: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2024 Jun; Vol. 7 (6), pp. e2083.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print Cited Medium: Internet ISSN: 2573-8348 (Electronic) Linking ISSN: 25738348 NLM ISO Abbreviation: Cancer Rep (Hoboken) Subsets: MEDLINE

مواضيع طبية MeSH: Geriatric Assessment*/methods , Neoplasms*/psychology , Clinical Trials, Phase I as Topic*, Humans ; Aged ; Female ; Male ; Aged, 80 and over ; Surveys and Questionnaires ; Cognitive Dysfunction/diagnosis ; Cognitive Dysfunction/epidemiology ; Cognitive Dysfunction/psychology ; Feasibility Studies ; Mass Screening/methods

المؤلفون: Shi H; Department of Statistics and Actuarial Science, Simon Fraser University, Burnaby, British Columbia, Canada., Lin R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lin X; School of Data Science, Fudan University, Shanghai, China.

المصدر: Biometrical journal. Biometrische Zeitschrift [Biom J] 2024 Jun; Vol. 66 (4), pp. e2300398.

نوع المنشور: Journal Article; Comparative Study; Research Support, N.I.H., Extramural; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-VCH Verlag GmbH & Co. KGaA Country of Publication: Germany NLM ID: 7708048 Publication Model: Print Cited Medium: Internet ISSN: 1521-4036 (Electronic) Linking ISSN: 03233847 NLM ISO Abbreviation: Biom J Subsets: MEDLINE

مواضيع طبية MeSH: Clinical Trials, Phase I as Topic*/methods , Clinical Trials, Phase II as Topic*/methods , Models, Statistical* , Biometry*/methods, Humans ; Research Design

المؤلفون: Chiuzan C; Northwell Health, New Hyde Park, NY, USA.; Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA., Dehbi HM; Comprehensive Clinical Trials Unit, University College London, London, UK.

المصدر: Clinical trials (London, England) [Clin Trials] 2024 Jun; Vol. 21 (3), pp. 350-357. Date of Electronic Publication: 2024 Apr 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 101197451 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1740-7753 (Electronic) Linking ISSN: 17407745 NLM ISO Abbreviation: Clin Trials Subsets: MEDLINE

مواضيع طبية MeSH: Maximum Tolerated Dose* , Research Design* , Bayes Theorem* , Clinical Trials, Phase I as Topic*/methods , Algorithms* , Computer Simulation* , Dose-Response Relationship, Drug*, Humans ; Sample Size ; Models, Statistical

المؤلفون: Zang Y; Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, IN, USA.; Center for Computational Biology and Bioinformatics, School of Medicine, Indiana University, Indianapolis, IN, USA., Guo B; Department of Experimental Statistics, Louisiana State University, Baton Rouge, LA, USA., Qiu Y; Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, IN, USA., Liu H; Department of Biostatistics and Epidemiology, Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA., Opyrchal M; Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN, USA., Lu X; Department of Medical and Molecular Genetics, School of Medicine, Indiana University, Indianapolis, IN, USA.

المصدر: Clinical trials (London, England) [Clin Trials] 2024 Jun; Vol. 21 (3), pp. 298-307. Date of Electronic Publication: 2024 Jan 11.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 101197451 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1740-7753 (Electronic) Linking ISSN: 17407745 NLM ISO Abbreviation: Clin Trials Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy , Neoplasms*/therapy , Immunotherapy*/methods , Clinical Trials, Phase I as Topic*/methods , Research Design* , Clinical Trials, Phase II as Topic*/methods, Humans ; Dose-Response Relationship, Drug ; Molecular Targeted Therapy/methods ; Algorithms ; Adaptive Clinical Trials as Topic/methods

المؤلفون: Stockton SS; Vanderbilt University Medical Center, 1211 Medical Center Drive, 37232, Nashville, TN, USA. Shannon.s.stockton.1@vumc.org., Ayers GD; Vanderbilt University Medical Center, 1211 Medical Center Drive, 37232, Nashville, TN, USA., Lee C; Vanderbilt University Medical Center, 1211 Medical Center Drive, 37232, Nashville, TN, USA., Laferriere H; Vanderbilt University, Nashville, TN, USA., Das S; Cullgen, Inc, San Diego, CA, USA., Berlin J; Vanderbilt University Medical Center, 1211 Medical Center Drive, 37232, Nashville, TN, USA.

المصدر: Investigational new drugs [Invest New Drugs] 2024 Jun; Vol. 42 (3), pp. 326-334. Date of Electronic Publication: 2024 May 22.

نوع المنشور: Journal Article; Systematic Review

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy , Neoplasms*/therapy , Precision Medicine* , Clinical Trials, Phase I as Topic*, Humans ; Antineoplastic Agents/therapeutic use ; Molecular Targeted Therapy ; Immunotherapy ; Medical Oncology